SensUs is a biosensor competition for students coordinated by Eindhoven University of Technology (www.sensus.org). Aim is to stimulate the development of sensing technologies for healthcare.

HyTest sponsored SensUs in 2017 when the target molecule was NT-proBNP. In 2022 the aim is to make biosensors for measuring acute inflammation focusing on sepsis. Target molecule is interleukin-6 and we will again sponsor SensUs teams by providing IL-6 antibodies and antigens to them.

17 international teams from 14 different countries are expected to develop innovative biosensing systems to detect interleukin-6 (IL-6) in blood. Teams will present their biosensors during SensUs Innovation Days on 30 Aug-2 Sep, 2022 in Eindhoven, the Netherlands. Biosensors will be judged on multiple criteria by representatives of academia, industry and healthcare.

Good luck to all teams!